Literature DB >> 11270831

Early effects of PRS-irradiation for 9L gliosarcoma: characterization of interphase cell death.

H Kurita1, C B Ostertag, B Baumer, K Kopitzki, P C Warnke.   

Abstract

We characterized the interphase cell death of 9L gliosarcoma after high-dose-rate, low-energy photon irradiation using the Photon Radiosurgery System (PRS), a novel device for interstitial radiotherapy. Within 24 hours after irradiation with a dose of 18 Gray, 22.0% of cells underwent metabolic cell death, whereas dead cells in controls stayed less than 5.0% (p<0.005). In the majority of sensitive cells, loss of membrane integrity preceded the lethal morphological changes. The response was dose-dependent over the range of 9-18 Gray, but saturation was obtained over 18 Gray. On the other hand, a significant (p < 0.01) increase in the number of TUNEL-positive cells with apoptotic morphology was detected 6-24 hours after irradiation, but the fraction remained 1.9-2.1% of the population and was independent of the doses between 9 and 25 Gray. Apoptotic cells were rarely observed in the control cells (0.3-0.6%). Our data indicate that single high-dose irradiation induces both necrotic and apoptotic interphase cell death in 9L gliosarcoma, but rapid cell death mostly occurs through the non-apoptotic pathway.

Entities:  

Mesh:

Year:  2000        PMID: 11270831     DOI: 10.1055/s-2000-11373

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  2 in total

1.  Combined low dose ionizing radiation and green tea-derived epigallocatechin-3-gallate treatment induces human brain endothelial cells death.

Authors:  Nancy McLaughlin; Borhane Annabi; Marie-Paule Lachambre; Kwang Sik Kim; Jean-Paul Bahary; Robert Moumdjian; Richard Béliveau
Journal:  J Neurooncol       Date:  2006-05-19       Impact factor: 4.130

2.  Sodium MRI at 7T for Early Response Evaluation of Intracranial Tumors following Stereotactic Radiotherapy Using the CyberKnife.

Authors:  L Huang; J Bai; R Zong; J Zhou; Z Zuo; X Chai; Z Wang; J An; Y Zhuo; F Boada; X Yu; Z Ling; B Qu; L Pan; Z Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2022-02       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.